A vascular disrupting agent overcomes tumor multidrug resistance by skewing macrophage polarity toward the M1 phenotype.
| Author | |
|---|---|
| Year of Publication |
:
2018
|
| Journal |
:
Cancer letters
|
| Date Published |
:
2018
|
| ISSN Number |
:
0304-3835
|
| DOI |
:
10.1016/j.canlet.2018.01.016
|
| Short Title |
:
Cancer Lett
|
| Download citation |
